Loeffler endocarditis: What have we learned?

American Journal of Hematology

Volumn 82, Issue 10, 2007, Pages 861-862

  Benezet Mazuecos, Juan ^a,b   De La Fuente, Adolfo ^a   Marcos Alberca, Pedro ^a   Farre, Jeronimo ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GADOLINIUM; HYDROXYUREA; IMATINIB; PREDNISONE;

CLINICAL FEATURE; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; ELECTRON MICROSCOPY; ENDOCARDITIS; EOSINOPHILIA; FOLLOW UP; HEART FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART VENTRICLE SIZE; HUMAN; HYPEREOSINOPHILIC SYNDROME; IMAGE ANALYSIS; LOEFFLER ENDOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; SYMPTOM; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

CARDIOVASCULAR AGENTS; HEART FAILURE, CONGESTIVE; HUMANS; HYPEREOSINOPHILIC SYNDROME; MODELS, BIOLOGICAL; PIPERAZINES; PYRIMIDINES;

EID: 34848862224     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20957     Document Type: Short Survey

References (22)

1. Loeffler W. Endocarditis parietalis fibroplastica mit Bluteosinophilie. Schweiz Med Wochenschr 1936;65:817-820.
2. Corssmit EP, Trip MD, Durrer JD. Loffler's endomyocarditis in the idiopathic hypereosinophilic syndrome. Cardiology 1999;91:272-276.
3. Bain BJ. Eosinophilia - Idiopathic or not? N Engl J Med 1999;341:1141-1143.
4. Fauci AS, Harley JB, Roberts WC, et al. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 1982;97:78-92.
5. Hayashi S, Isobe M, Okubo Y, et al. Improvement of eosinophilic heart disease after steroid therapy: Successful demonstration by endomyocardial biopsied specimens. Heart Vessels 1999;14:104-108.
6. Gottdiener JS, Maron BJ, Schooley RT, et al. Two-dimensional echocardiographic assessment of the idiopathic hypereosinophilic syndrome. Anatomic basis of mitral regurgitation and peripheral embolization. Circulation 1983;67: 572-578.
7. Berensztein CS, Pineiro D, Marcotegui M, et al. Usefulness of echocardiography and doppler echocardiography in endomyocardial fibrosis. J Am Soc Echocardiogr 2000;13:385-392.
8. Pinar Sopena J, Candell Riera J, San Jose Laporte A, et al. Echocardiography manifestations in patients with hypereosinophilia. Rev Esp Cardiol 1990;43:450-456.
9. Acquatella H, Schiller NB, Puigbo JJ, et al. Value of two-dimensional echocardiography in endomyocardial disease with and without eosinophilia. A clinical and pathologic study. Circulation 1983;67:1219-1226.
10. Tandri H, Saranathan M, Rodriguez ER, et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005;45:98-103.
11. Benezet-Mazuecos J, Marcos-Alberca P, Farre J, et al. Early differential resolution of right and left ventricular obliteration in Loffler endocarditis after chemotherapy and anticoagulation. Circulation 2006;114:e635-e637.
12. Lofiego C, Ferlito M, Rocchi G, et al. Ventricular remodeling in Loeffler endocarditis: Implications for therapeutic decision making. Eur J Heart Fail 2005;7:1023-1026.
13. Parrillo JE, Borer JS, Henry WL, et al. The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature. Am J Med 1979;67:572-582.
14. Chao BH, Cline-Parhamovich K, Grizzard JD, Smith TJ. Fatal Loeffler's endocarditis due to hypereosinophilic syndrome. Am J Hematol 2007 May 29 [Epub ahead of print].
15. Parrillo JE, Fauci AS, Wolff SM. Therapy of the hypereosinophilic syndrome. Ann Intern Med 1978;89:167-172.
16. Schandene L, Roufosse F, de Lavareille A, et al. Interferon α prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia. Blood 2000;96:4285-4292.
17. Bockenstedt PL, Santinga JT, Bolling SF. α-Interferon treatment for idiopathic hypereosinophilic syndrome. Am J Hematol 1994;45:248-251.
18. Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003;348: 1201-1214.
19. Rotoli B, Catalano L, Galderisi M, et al. Rapid reversion of Loeffler's endocarditis by imatinib in early stage clonal hypereosinophilic syndrome. Leuk Lymphoma 2004;45:2503-2507.
20. Hunt SA, Abraham WT, Chin MH, et al.; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-e235.
21. Ommen SR, Seward JB, Tajik AJ. Clinical and echocardiographic features of hypereosinophilic syndromes. Am J Cardiol 2000;86:110-113.
22. Bishop GG, Bergin JD, Kramer CM. Hypereosinophilic syndrome and restrictive cardiomyopathy due to apical thrombi. Circulation 2001;104:E3-E4.